88 related articles for article (PubMed ID: 3764453)
21. Hyperprolactinaemia in Zimbabwean women.
Kasule J; Chimbira TH
Cent Afr J Med; 1987 Jul; 33(7):173-8. PubMed ID: 3455362
[No Abstract] [Full Text] [Related]
22. Prolactin-producing microadenomas in pregnancy.
Divers WA; Yen SS
Obstet Gynecol; 1983 Oct; 62(4):425-9. PubMed ID: 6888819
[TBL] [Abstract][Full Text] [Related]
23. Prolactinoma and bromocriptine therapy.
Skaf RA
N J Med; 1986 Jul; 83(7):455-60. PubMed ID: 3528940
[No Abstract] [Full Text] [Related]
24. Evaluation and treatment of hyperprolactinaemia in women of childbearing age.
Marek J; Zivný J; Srámková J; Kucera E; Kobilková J
Acta Univ Palacki Olomuc Fac Med; 1981; 101():110-7. PubMed ID: 6242681
[No Abstract] [Full Text] [Related]
25. Delivery after bromocriptine therapy.
Modena G; Portioli I
Lancet; 1977 Sep; 2(8037):558. PubMed ID: 95756
[No Abstract] [Full Text] [Related]
26. [Therapeutic results in hyperprolactinemic sterility patients].
Melzer H
Zentralbl Gynakol; 1987; 109(8):517-20. PubMed ID: 3604494
[TBL] [Abstract][Full Text] [Related]
27. Prolactinoma during pregnancy causing compression symptoms responding to bromocriptine therapy.
Saunders NJ
Postgrad Med J; 1985 Sep; 61(719):829-30. PubMed ID: 4059146
[TBL] [Abstract][Full Text] [Related]
28. Long-acting injectable bromocriptine treatment for macroprolactinomas.
Van Cutsem EJ; Lamberts SW
Neth J Med; 1988 Apr; 32(3-4):112-7. PubMed ID: 3362265
[No Abstract] [Full Text] [Related]
29. [Hyperprolactinemia and pregnancy].
Ionescu O; Vulpoi C; Cristea C; Ionescu D; Zbranca E
Rev Med Chir Soc Med Nat Iasi; 2002; 106(1):60-4. PubMed ID: 12635361
[TBL] [Abstract][Full Text] [Related]
30. Computed tomographic demonstration of the effects of bromocriptine on pituitary microadenoma size.
Bonneville JF; Poulignot D; Cattin F; Couturier M; Mollet E; Dietemann JL
Radiology; 1982 May; 143(2):451-5. PubMed ID: 7071347
[TBL] [Abstract][Full Text] [Related]
31. Follow-up of children born of bromocriptine-treated mothers.
Raymond JP; Goldstein E; Konopka P; Leleu MF; Merceron RE; Loria Y
Horm Res; 1985; 22(3):239-46. PubMed ID: 4054844
[TBL] [Abstract][Full Text] [Related]
32. Current treatment issues in female hyperprolactinaemia.
Crosignani PG
Eur J Obstet Gynecol Reprod Biol; 2006 Apr; 125(2):152-64. PubMed ID: 16288952
[TBL] [Abstract][Full Text] [Related]
33. Does treatment with bromocriptine influence the course of hyperprolactinaemia?
Glasier AF; Hendry RA; Seth J; Baird DT
Clin Reprod Fertil; 1987 Dec; 5(6):359-66. PubMed ID: 3505830
[TBL] [Abstract][Full Text] [Related]
34. [Current status of gynecologic hormone therapy. Prolactin-induced disorders].
Schneider HP
Arch Gynecol; 1985; 238(1-4):697-705. PubMed ID: 4073958
[No Abstract] [Full Text] [Related]
35. Hyperprolactinaemia.
Prabhakar VK; Davis JR
Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):341-53. PubMed ID: 17889620
[TBL] [Abstract][Full Text] [Related]
36. [Complete regression of prolactin-secreting pituitary tumors by bromocriptine therapy (author's transl)].
Munemitsu H; Matsuda M; Hirai O; Kawamura J; Matsubayashi K; Fukuyama H
No Shinkei Geka; 1980 Oct; 8(10):981-6. PubMed ID: 7442930
[No Abstract] [Full Text] [Related]
37. Hyperprolactinemia and lens opacities.
Costagliola C; Mastropasqua L; Amato G; Carella C
Ann Ophthalmol; 1992 Nov; 24(11):418-9. PubMed ID: 1476397
[TBL] [Abstract][Full Text] [Related]
38. Prolactin levels in infertility and bromocriptine therapy in hyperprolactinaemia.
Prathibha D; Govardhani M; Krishna PT
J Indian Med Assoc; 1994 Dec; 92(12):397-9. PubMed ID: 7876578
[TBL] [Abstract][Full Text] [Related]
39. Dopamine agonists and pituitary tumor shrinkage.
Bevan JS; Webster J; Burke CW; Scanlon MF
Endocr Rev; 1992 May; 13(2):220-40. PubMed ID: 1352243
[TBL] [Abstract][Full Text] [Related]
40. [Pregnancy in hyperprolactinemic patients].
Ventz M; Puhlmann B; Knappe G; Gerl H; Lehmann R; Rohde W
Zentralbl Gynakol; 1996; 118(11):610-5. PubMed ID: 9082694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
